WuXi PharmaTech Laboratory testing division expands in U.S. with acquisition of XenoBiotic
WuXi PharmaTech announced it has acquired XenoBiotic Laboratories, a CRO with 27 years of successful operation that provides bioanalytical, drug metabolism, and pharmacokinetic services to the pharmaceutical, animal health, and agrochemical industries. Financial terms were not disclosed. October 01, 2014